4//SEC Filing
DAVIS A BRIAN 4
Accession 0001209191-19-053716
CIK 0001660334other
Filed
Oct 20, 8:00 PM ET
Accepted
Oct 21, 4:49 PM ET
Size
5.6 KB
Accession
0001209191-19-053716
Insider Transaction Report
Form 4
DAVIS A BRIAN
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-10-18+125,000→ 125,000 totalExercise: $14.65Exp: 2029-10-18→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]25% of the total shares subject to the option shall vest on October 18, 2020 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date.
Documents
Issuer
Verrica Pharmaceuticals Inc.
CIK 0001660334
Entity typeother
Related Parties
1- filerCIK 0001184432
Filing Metadata
- Form type
- 4
- Filed
- Oct 20, 8:00 PM ET
- Accepted
- Oct 21, 4:49 PM ET
- Size
- 5.6 KB